Enregistré dans:
| Auteurs principaux: | Miao Fan, Xuan Yin, Yiyi Jin, Xiaomeng Zheng, Suyan Zhu |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2025
|
| Sujets: | |
| Accès en ligne: | https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.16396 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Relevance of selected pharmacogenetic polymorphisms to bleeding and thromboembolic risks in Chinese patients taking direct‐acting oral anticoagulants
par: Dongxu Wang, et autres
Publié: (2025)
par: Dongxu Wang, et autres
Publié: (2025)
Association between oral anticoagulant therapy and in‐hospital complications and mortality
par: Juliana Lagrave, et autres
Publié: (2025)
par: Juliana Lagrave, et autres
Publié: (2025)
Dicloxacillin is an inducer of intestinal P‐glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users
par: Ditte B. Iversen, et autres
Publié: (2024)
par: Ditte B. Iversen, et autres
Publié: (2024)
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer
par: Catharina J. P. Op 't Hoog, et autres
Publié: (2025)
par: Catharina J. P. Op 't Hoog, et autres
Publié: (2025)
Prescriptions of CYP3A4‐ and P‐gp inducers for patients on direct oral anticoagulants: Bridging the gap between epidemiology and patient management for optimal thromboembolic event prevention
par: Stephanie C. M. Wuyts, et autres
Publié: (2025)
par: Stephanie C. M. Wuyts, et autres
Publié: (2025)
Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards
par: Antonio De Vincentis, et autres
Publié: (2024)
par: Antonio De Vincentis, et autres
Publié: (2024)
Pharmacological evaluation of non‐nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury
par: Inés Valencia, et autres
Publié: (2025)
par: Inés Valencia, et autres
Publié: (2025)
Anticoagulation reversal (vitamin K, prothrombin complex concentrates, idarucizumab, andexanet‐α, protamine)
par: Elias Bekka, et autres
Publié: (2024)
par: Elias Bekka, et autres
Publié: (2024)
Integrative immunomodulation in systemic autoimmune diseases: Mechanistic complementarity and therapeutic strategies of traditional Chinese and conventional medicine
par: Xiaomeng Zhang, et autres
Publié: (2026)
par: Xiaomeng Zhang, et autres
Publié: (2026)
Investigation of absorption, metabolism, and excretion of [ 14 C]pruxelutamide (GT0918), an androgen receptor antagonist in humans
par: Yuan‐dong Zheng, et autres
Publié: (2025)
par: Yuan‐dong Zheng, et autres
Publié: (2025)
How could perampanel, a potent AMPAergic antagonist, inhibit seizures but largely spare normal neurotransmission?
par: Cho‐Ming Lee, et autres
Publié: (2026)
par: Cho‐Ming Lee, et autres
Publié: (2026)
Intranasal vitamin B12 administration in elderly patients: A randomized controlled comparison of two dosage regimens
par: Monique P. H. Tillemans, et autres
Publié: (2024)
par: Monique P. H. Tillemans, et autres
Publié: (2024)
A vitamin D‐based strategy overcomes chemoresistance in prostate cancer
par: Kateryna Len‐Tayon, et autres
Publié: (2024)
par: Kateryna Len‐Tayon, et autres
Publié: (2024)
Direct neuronal protection by the protease‐activated receptor PAR4 antagonist ML354 after experimental stroke in mice
par: Michael Fleischer, et autres
Publié: (2024)
par: Michael Fleischer, et autres
Publié: (2024)
Sodium‐glucose cotransporter‐2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
par: Samantha B. Shapiro, et autres
Publié: (2024)
par: Samantha B. Shapiro, et autres
Publié: (2024)
The fast‐dissociating D 2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment
par: Lidia Carotenuto, et autres
Publié: (2025)
par: Lidia Carotenuto, et autres
Publié: (2025)
Efficiency of computerized clinical decision support systems involving anticoagulants: A flashmob study in Dutch hospital pharmacies
par: Jetske Graafsma, et autres
Publié: (2024)
par: Jetske Graafsma, et autres
Publié: (2024)
Discrepancies between forest plots and reported results in mineralocorticoid receptor antagonist meta‐analysis of glycaemic outcomes
par: Lekha Saha
Publié: (2026)
par: Lekha Saha
Publié: (2026)
ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents
par: Omar Soler‐Cedeño, et autres
Publié: (2025)
par: Omar Soler‐Cedeño, et autres
Publié: (2025)
Maternal exposure to folate antagonists and susceptibility to congenital heart disease in offspring: A systematic review and meta‐analysis
par: Prajjwol Luitel, et autres
Publié: (2024)
par: Prajjwol Luitel, et autres
Publié: (2024)
The interplay between molecular architecture, pharmacology, and suspected adverse drug reactions associated with nonsteroidal androgen antagonists in the United Kingdom
par: Simrit Dhillon, et autres
Publié: (2026)
par: Simrit Dhillon, et autres
Publié: (2026)
Pharmacodynamics of the orexin type 1 (OX1) receptor in colon cancer cell models: A two‐sided nature of antagonistic ligands resulting from partial dissociation of Gq
par: Valérie Gratio, et autres
Publié: (2024)
par: Valérie Gratio, et autres
Publié: (2024)
A comprehensive review of anti‐colorectal cancer alkaloids from traditional Chinese medicine: Sources, chemical structures, mechanisms and therapeutic applications
par: Kaiping Cong, et autres
Publié: (2026)
par: Kaiping Cong, et autres
Publié: (2026)
Development and validation of a clinical risk score nomogram for predicting clozapine plasma concentrations below 350 ng/mL: A retrospective cohort study
par: Jing Ding, et autres
Publié: (2025)
par: Jing Ding, et autres
Publié: (2025)
Exposure–response relationship of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis
par: Yizhe Chen, et autres
Publié: (2025)
par: Yizhe Chen, et autres
Publié: (2025)
Inter‐regional pharmacokinetics and exposure–response analyses of belimumab in patients with system lupus erythematosus
par: Junyi Wu, et autres
Publié: (2024)
par: Junyi Wu, et autres
Publié: (2024)
Safe and supportive prescribing in transgender and non‐binary patients with cancer
par: Mariachiara D'Elia, et autres
Publié: (2024)
par: Mariachiara D'Elia, et autres
Publié: (2024)
Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment
par: Shibeilei Lin, et autres
Publié: (2025)
par: Shibeilei Lin, et autres
Publié: (2025)
Model‐based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis
par: Jin‐Meng Li, et autres
Publié: (2024)
par: Jin‐Meng Li, et autres
Publié: (2024)
An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain
par: Janine Kutzsche, et autres
Publié: (2024)
par: Janine Kutzsche, et autres
Publié: (2024)
Development of a predictive model for neutropenia risk in Japanese breast cancer patients treated with doxorubicin and cyclophosphamide
par: Takehiro Miyagi, et autres
Publié: (2025)
par: Takehiro Miyagi, et autres
Publié: (2025)
The first in‐human study to evaluate the antiplatelet properties of the clopidogrel conjugate DT‐678 in acute coronary syndrome patients and healthy volunteers
par: Zhihao Liu, et autres
Publié: (2024)
par: Zhihao Liu, et autres
Publié: (2024)
STRATIfy‐PK SCORE: A predictive tool for identifying pharmacokinetic failure risk in anti‐TNF–treated patient
par: Carles Iniesta‐Navalón, et autres
Publié: (2025)
par: Carles Iniesta‐Navalón, et autres
Publié: (2025)
Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling
par: Mingdian Tan, et autres
Publié: (2025)
par: Mingdian Tan, et autres
Publié: (2025)
Deprescribing drugs with anticholinergic effects in older patients with increased risk of dementia in the multicomponent intervention study AgeWell.de
par: Laura K. Lepenies, et autres
Publié: (2025)
par: Laura K. Lepenies, et autres
Publié: (2025)
Exploring the antidepressant potential of Yueju Pill: Insights from traditional Chinese medicine
par: Xinyan Wu, et autres
Publié: (2026)
par: Xinyan Wu, et autres
Publié: (2026)
Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending‐dose study in healthy young men
par: Christian Friedrich, et autres
Publié: (2024)
par: Christian Friedrich, et autres
Publié: (2024)
External validation of the BAN‐ADHF diuretic‐resistance score in the DAPA‐RESIST clinical trial
par: Dominic M. Alfonso, et autres
Publié: (2026)
par: Dominic M. Alfonso, et autres
Publié: (2026)
Early therapeutic drug monitoring helps to identify inflammatory bowel disease patients with a high risk to fail thiopurine treatment
par: Debbie S. Deben, et autres
Publié: (2024)
par: Debbie S. Deben, et autres
Publié: (2024)
Risk of venous thromboembolism after SARS‐CoV‐2 vaccination—Evidence from genome‐wide association study and population‐based observational study
par: Sofia Attelind, et autres
Publié: (2026)
par: Sofia Attelind, et autres
Publié: (2026)
Documents similaires
-
Relevance of selected pharmacogenetic polymorphisms to bleeding and thromboembolic risks in Chinese patients taking direct‐acting oral anticoagulants
par: Dongxu Wang, et autres
Publié: (2025) -
Association between oral anticoagulant therapy and in‐hospital complications and mortality
par: Juliana Lagrave, et autres
Publié: (2025) -
Dicloxacillin is an inducer of intestinal P‐glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users
par: Ditte B. Iversen, et autres
Publié: (2024) -
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer
par: Catharina J. P. Op 't Hoog, et autres
Publié: (2025) -
Prescriptions of CYP3A4‐ and P‐gp inducers for patients on direct oral anticoagulants: Bridging the gap between epidemiology and patient management for optimal thromboembolic event prevention
par: Stephanie C. M. Wuyts, et autres
Publié: (2025)